Home / Founders / Ken Song

Ken Song

Founder of Candid Therapeutics

Ken Song

Backed by

Franklin Templeton
Polaris Partners
Jon Flint
Rupert H. Johnson
Steve Arnold

Sources

Candid, with $370M, sets out to prove bispecifics’ worth in autoimmune disease — 2024-09

Browse all founders · Browse investors